Fundz

Convergent Therapeutics reported raising $29.2 Million in an initial SEC Form D filing, from an offering of $99.2 Million

PRIVATEMay 22, 2023$29.2M of $99.2M raised

Amount Raised

$29.2 Million

$29.2 Million sold, per SEC Form D (first sale Apr 27, 2023)

Round Type

Venture

CambridgeBiotechnologyHealth CareTherapeutics

Quick answer

Convergent Therapeutics raised $29.2 Million in a funding round, dated April 27, 2023. Convergent Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Convergent Therapeutics raise?
Convergent Therapeutics raised $29.2 Million in a funding round on April 27, 2023.
What does Convergent Therapeutics do?
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer.
Where is Convergent Therapeutics based and how big is it?
Convergent Therapeutics is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Convergent Therapeutics?
Fundz holds 1 contact at Convergent Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Convergent Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Kate Therapeutics raised $51M (Series A) on June 8, 2023.
  • Acepodia raised $100M (Series D) on June 6, 2023.
  • Alkeus Pharmaceuticals raised $150M (Series B) on June 5, 2023.
  • Cyclo Therapeutics raised an undisclosed amount (Post-IPO Equity) on June 5, 2023.
  • Phio Pharmaceuticals raised $3M (Seed) on June 2, 2023.
  • Visgenx, Inc. raised $5.7M (Seed) on June 2, 2023.

Who to call at Convergent Therapeutics, and when

A new round usually means Convergent Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Convergent Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Convergent Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Convergent Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Convergent Therapeutics

Location

Cambridge, Massachusetts, United States

About

Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules like Prostate-Specific Membrane Antigen (PSMA) improves antitumor efficacy. By leveraging targeting agents with different bio-distributions, such as monoclonal antibodies and ligands, supra-additive therapeutic doses are delivered to tumor cells without additive toxicity to the patient.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Convergent Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Convergent Therapeutics's next move

See what Strategic adds

Convergent Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.